Glucocorticoids (GCs) and their analogs regulate downstream gene expression through the glucocorticoid receptor (GR, also known as NR3C1), which is a member of the nuclear receptor superfamily of ligand-activated transcription factors. GCs diffuse into the cytoplasm, bind to GR, and are then translocated to the nucleus, where they bind to glucocorticoid response elements (GREs) in the promoters of target genes, thereby activating or repressing gene expression. GCs also modulate gene expression via non-GR pathways, such as through cAMP response element-binding (CREB) protein, activator protein (AP)-1, and NF-κB. These receptors have several major domains, including an amino-terminal activation domain, a central zinc-finger DNA-binding domain, and a carboxy-terminal ligand-binding domain. This system can be used to study the activation levels of glucocorticoid-mediated signaling pathways, drug research, and gene overexpression and RNAi phenotypic analysis.